dc.contributor.author | Cebeci, E | |
dc.contributor.author | Toprak, ID | |
dc.contributor.author | Toprak, Z | |
dc.contributor.author | Helvaci, SA | |
dc.contributor.author | Tukek, Tufan | |
dc.contributor.author | Sakin, A | |
dc.contributor.author | Kutlu, Y | |
dc.date.accessioned | 2021-03-03T17:44:52Z | |
dc.date.available | 2021-03-03T17:44:52Z | |
dc.identifier.citation | Toprak Z., Cebeci E., Helvaci S., Toprak I., Kutlu Y., Sakin A., Tukek T., "Cisplatin nephrotoxicity is not detected by urinary cell-cycle arrest biomarkers in lung cancer patients.", International urology and nephrology, cilt.49, ss.1041-1047, 2017 | |
dc.identifier.issn | 0301-1623 | |
dc.identifier.other | vv_1032021 | |
dc.identifier.other | av_4b423b67-feb5-4fbd-96bb-46102e6625ca | |
dc.identifier.uri | http://hdl.handle.net/20.500.12627/54029 | |
dc.identifier.uri | https://doi.org/10.1007/s11255-017-1556-4 | |
dc.language.iso | eng | |
dc.title | Cisplatin nephrotoxicity is not detected by urinary cell-cycle arrest biomarkers in lung cancer patients. | |
dc.type | Makale | |
dc.relation.journal | International urology and nephrology | |
dc.contributor.department | , , | |
dc.identifier.volume | 49 | |
dc.identifier.startpage | 1041 | |
dc.identifier.endpage | 1047 | |
dc.contributor.firstauthorID | 733027 | |